US buys entire three-month supply of anti-Covid drug remdesivir

Remdesivir is an anti-viral drug that was developed for use against Ebola. It speeds up recovery time from the disease.

The Trump administration has bought up virtually all stocks for the next three months of a drug shown to work against Covid-19.

The US Department of Health and Human Services (HSS) said it had secured more than 500,000 treatment courses of remdesivir for American hospitals.